Phase 2 Vitiligo Trial, Recruiting NCT07595705 Sponsor: Cairo University Condition: Vitiligo
Back to Vitiligo

Phase 2 Vitiligo Trial, Recruiting

NCT07595705
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have some visible dark (brown to black) spots, patches, or widespread darkening of the gums (based on a specific gum pigmentation scoring system used by dentists)
  • You are 18 years of age or older
  • You are in generally good overall health with no systemic (whole-body) illnesses
  • Your gum darkening is a natural, harmless variation in the visible/smile area and is not caused by disease
  • You have good oral hygiene and are willing to have a minor dental/surgical procedure

Who may not be able to join:

  • You have a medical condition that causes abnormal skin or gum darkening, or that affects how your body heals wounds (such as uncontrolled diabetes or autoimmune diseases)
  • You are currently pregnant or breastfeeding
  • You are currently using antiseptic mouth rinses such as chlorhexidine or povidone iodine
  • Your gum darkening is related to smoking
  • You have active gum or periodontal (teeth and gum) disease, such as gingivitis or periodontitis
  • You are unlikely to follow through with the treatment plan or attend required appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Nourhan A Abdullah, Phd, Lecturer at faculty of dentistry, Fayoum university

Phone: 01005802478

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Degree of gingival pigmentation by Takashi index (Hanioka et al., 2005); Degree of gingival pigmentation by Gingival pigmentation index (Kumar et al., 2013)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov